CONMED Corporation (CNMD)

Market Cap	1.09B -39.0%
Revenue (ttm)	1.37B +4.1%
Net Income	54.85M -53.8%
EPS	1.77 -53.6%
Shares Out	30.11M
PE Ratio	20.44
Forward PE	8.01
Dividend	$0.40 (1.11%)
Ex-Dividend Date	Sep 15, 2025

Volume	262,973
Open	36.56
Previous Close	36.61
Day's Range	35.70 - 37.24
52-Week Range	33.21 - 60.80
Beta	0.94
Analysts	Hold
Price Target	39.60 (+9.45%)
Earnings Date	Apr 29, 2026

About CNMD

CONMED Corporation, a medical technology company, develops, manufactures, and sells devices and equipment for surgical procedures. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as supporting products include powered resection instruments , fluid management, and visualization systems an...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Jul 23, 1987
• Employees: 3,900
• Stock Exchange: NYSE
• Ticker Symbol: CNMD
• Website: https://www.conmed.com

Financial Performance

In 2025, CONMED's revenue was $1.37 billion, an increase of 5.18% compared to the previous year's $1.31 billion. Earnings were $47.06 million, a decrease of -64.47%.

Analyst Summary

According to 6 analysts, the average rating for CNMD stock is "Hold." The 12-month stock price target is $39.6, which is an increase of 9.45% from the latest price.

Price Target

$39.6

(9.45% upside)

Analyst Consensus: Hold